A case of low-grade fibromyxoid sarcoma with unusual central necrosis in a 77-year-old man confirmed by FUS-CREB3L2 gene fusion  by Kurisaki-Arakawa, Aiko et al.
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INTRODUCTION:  Low-grade  ﬁbromyxoid  sarcoma  (LGFMS)  is  a rare  soft tissue  tumor  typically  affecting
young  to middle-aged  adults.  Despite  its otherwise  benign  histologic  appearance  and  indolent  nature,
it  can  display  fully  malignant  behavior,  and  recurrence  and  metastasis  can  occur  even  decades  after
diagnosis.
PRESENTATION  OF  CASE:  Herein,  we  report  a case  of  LGFMS  in the  buttock  of a 77-year-old  man.  Mag-
netic  resonance  imaging  uncovered  a well-demarcated  tumor  measuring  27  ×  20  mm  with a slightly  high
intensity  on  T1-weighted  images  (WIs)  and  heterogeneously  high  intensity  on  T2-WIs.  Histologically,  the
tumor  was composed  of  bland  spindle-shaped  cells  in  a whorled  growth  pattern  with  alternating  ﬁbrous
and myxoid  stroma.  The  tumor  stroma  was  variably  hyalinized  with  arcades  of  curvilinear  capillaries
and  arterioles  with  associated  perivascular  ﬁbrosis.  Unusual  histology,  such  as  central  necrosis  and  cys-
tic formation,  was  also  noted.  Reverse  transcription  polymerase  chain  reaction  from  a  formalin-ﬁxed,
parafﬁn-embedded  biopsy  specimen  revealed  a FUS-CREB3L2  gene  fusion  (exon6/int/exon5),  leading  to
the  diagnosis  of LGFMS.
DISCUSSION:  To  the  best of  our  knowledge,  this  is the  second  oldest  patient  to be  diagnosed  with  LGFMS.
CONCLUSION:  At the  time  of  this  report,  the  patient  was  alive  with  no evidence  of the  disease  4  months
after  diagnosis  without  any  adjuvant  therapy.
©  2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Low-grade ﬁbromyxoid sarcoma (LGFMS) is a rare soft tis-
ue tumor that typically affects young to middle-aged adults.1,2
 large series of LGFMS cases demonstrated that the median age
f onset for this tumor is 34 years (range, 3–78 years).3 Histo-
ogically, LGFMS is composed of bland spindle-shaped cells in a
horled growth pattern, arranged in alternating myxoid and colla-
enized areas, along with curvilinear capillaries and characteristic
rterioles with perivascular ﬁbrosis. Heterotopic ossiﬁcation and
yst formation have also been reported in these tumors.4,5 While
GFMS usually exhibits otherwise benign histologic appearance,
 subset of tumors have been reported to show indolent progres-
ion, with many cases developing recurrence or metastasis decades
ater, mainly to the lung. Cytological atypia and tumor necro-
is is absent in LGFMS.6 However, approximately 30% of tumors
ave focal areas of intermediate- to high-grade sarcoma as shown
y hypercellularity, nuclear enlargement, hyperchromatism,
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necrosis, and high mitotic activity (>5/50 high-powered ﬁelds),
but the presence of these histologic features is not associated with
patient survival.3,5 Furthermore, approximately 40% of cases have
focal areas of hypocellular collagen cores rimmed by epithelioid
ﬁbroblasts, referred to as collagen pseudo-rosettes. Cases of promi-
nent collagen pseudo-rosettes are referred to as hyalinizing spindle
cell tumors with giant rosettes.7
A diagnosis of LGFMS is often difﬁcult by a small biopsy
specimen that can lead to a misdiagnosis of malignant tumors
as benign or as tumor-like lesions including nodular fasci-
itis, schwannoma, desmoid-type ﬁbromatosis, neuroﬁbroma, and
myxoﬁbrosarcoma.8–10 A recent study reported up-regulation of
the mucin 4 (MUC4)  gene in LGFMS compared to histologically
similar tumors and lesions,10,11 and MUC4 immunostaining was a
sensitive and speciﬁc marker of LGFMS in appropriate morphologic
context.2,7 Several recent studies demonstrated that more than
90% of LGFMS have a balanced chromosomal translocation t(7;16)
(q32–34;p11) leading to the fusion of the FUS and CREB3L2 genes,
while a minority of cases have a t(11;16) (p11;p11) translocation
leading to the fusion of the FUS and CREB3L1 genes.1,2,7–9,12 In one
report, a small number of LGFMS cases contained EWSR-CREB3L1
gene fusions.7,13
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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fig. 1. Magnetic resonance imaging (MRI) of the left buttock of a 77-year-old pat
ntensity compared to the skeletal muscle on T1-weighted images (WIs) (A) and h
ow  to slightly high signal intensity compared to the skeletal muscle on fat-suppres
Here, we report a rare case of LGFMS with central hemor-
hagic necrosis in a 77-year-old male patient. Reverse transcription
olymerase chain reaction (RT-PCR) from a formalin-ﬁxed,
arafﬁn-embedded (FFPE) biopsy specimen revealed FUS-CREB3L2
ene fusion (exon6/int/exon5), leading to the diagnosis of LGFMS.
o the best of our knowledge, this is the second oldest patient to
e reported with LGFMS.
. Case report
A 77-year-old man  was referred to our hospital with a pain-
ess mass in the left buttock, which had been gradually growing
ince he ﬁrst noticed it 10 years previously. A physical examination
evealed an elastic hard mass in the left buttock, and magnetic reso-
ance imaging (MRI) showed a well-demarcated tumor measuring
0 mm in maximum diameter with central hematoma formation.
he mass showed low intensity on T1-weighted images (WIs),
eterogeneously high intensity on T2-WI (Fig. 1A and B), and het-
rogeneously high signal intensity on fat-suppressed T1-WI (Fig. 1C
nd D). Chest and pelvic computed tomography (CT) revealed no
vidence of metastatic lesion.
Histopathologically, the tumor was composed of bland spindle-
haped cells with a whorled growth pattern on biopsy specimen.
he tumor stroma was ﬁbrous, and alternating ﬁbrous and myxoid
troma characteristic of LGFMS were unclear (Fig. 2A–C). The tumor
howed no nuclear pleomorphism, high cellularity. Focally, tumor
ells exhibited wavy appearance. Necrotic area was also observed
t the edge of the specimen. Mitosis was not observed. Differential
iagnosis on conventional hematoxylin and eosin staining included
esmoid-type ﬁbromatosis, schwannoma, and LGFMS. Immuno-
istochemically, the tumor cells were negative for S-100 protein
Fig. 2D) and nuclear staining of -catenin, which are typically
resent in desmoid-type ﬁbromatosis.
To determine the presence of FUS-CREB3L1 or FUS-CREB3L2
usion genes in the tumor, we performed RT-PCR on FFPE tumorRI revealed a well-deﬁned mass in the left buttock. The mass showed low signal
eneously high signal intensity on T2-WIs (B). The mass had heterologously mixed
1-WIs (C: coronal, D: sagittal).
tissue. Brieﬂy, ﬁve 10-m thick parafﬁn sections were cut from the
parafﬁn-embedded block. RNA was  isolated using the RNeasy FFPE
kit (QIAGEN, Hilden, Germany), puriﬁed, and reverse transcribed
to cDNA using the Superscript ﬁrst-strand synthesis system for
RT-PCR (Invitrogen, CA, USA). The primer sequences used for the
ampliﬁcation in this study have been previously described.14 The
PCR product was separated on a 2% agarose gel, and the PCR prod-
uct of the appropriate size was cut from the gel and sequenced.
Sequencing conﬁrmed the presence of a FUS-CREB3L2 fusion gene
in this tumor. This gene fusion occurred between the end of exon
6 of FUS and part of exon 5 of CREB3L2 with a 4-bp insertion of
unknown origin (Fig. 3A). Genomic DNA-based long PCR revealed a
gene fusion between the part of intron 6 of FUS and part of exon 5 of
CREB3L2. The 4-bp sequence at the end of intron 6 was identical to
that of a 4-bp insertion of the FUS-CREB3L2 fusion gene, suggesting
that the 4-bp insertion was  probably derived from the junctional
region of the fusion gene (Fig. 3B). Thus, the fusion gene in this case
was exon6/int6/exon5 of the FUS-CREB3L2.
A wide resection of the tumor was performed under a diag-
nosis of LGFMS. Macroscopically, the resected surface of the
surgical specimen was  whitish-gray with partial myxoid appear-
ance (Fig. 4A). Central hemorrhagic necrosis was  also observed.
Pathological analysis of the resected tumor revealed characteris-
tic alternating ﬁbrous and myxoid stroma with occasional cystic
formation (Fig. 4B–D). Four months after diagnosis, the patient was
alive with no evidence of the disease without any adjuvant therapy.
3. Discussion
LGFMS can occur at any age, but typically affects young to
middle-aged adults.1,2 Two large studies on LGFMS reported
that patient age at the time of diagnosis ranges between
6–52 years and 3–78 years, respectively.3,5 In the current case,
with the long duration of the tumor and cystic changes on
MRI, the differential diagnosis on biopsy specimen included
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uig. 2. Tumor histology of the biopsy specimen. Tumor cells were proliferating in 
he  tumor cells showed wavy nuclei, and nuclear atypia was not evident on high-p
umor  (C). Immunohistochemically, tumor cells were negative for S-100 protein (Dncient/degenerative schwannoma by less atypical spindle shaped
ells in the ﬁbrous stroma, because alternating ﬁbrous and myxoid
troma were unclear on the biopsy specimen. Low-grade myxoﬁ-
rosarcoma (LGMFS) was also an important differential diagnosis
ig. 3. Detection of a FUS-CREB3L2 fusion in the LGFMS tumor. RT-PCR on FFPE-derived RN
f  CREB3L2 exon 5 with a 4-bp insertion (red underline) of unknown origin (A). Genome s
nderline) at the junctional region of cDNA sequence was identical to that of the last 4-bprous stroma, but alternating ﬁbrous and myxoid areas were unclear (A). Some of
iew (B). Degenerative area with focal necrosis was present at the periphery of theconsidering the age of this patient. Patients with LGMFS are
reported to be signiﬁcantly older than those with LGFMS,
and LGMFS more frequently occurs in a superﬁcial location.6
Furthermore, desmoid-type ﬁbromatosis would clinically and
A was performed. DNA sequencing revealed a fusion between FUS exon 6 and part
equencing of the fusion gene revealed that the sequence of the 4-bp insertion (red
 sequence of intron 6 of FUS at the junctional region (B).
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tig. 4. Tumor histology of the resected tumor. The surgically resected intramuscul
umor  (A). Histologically, the surgically resected tumor was  composed of an admixtu
umor  cells was  observed (C). Massive hemorrhagic necrosis was  observed at the ce
adiolodically be also another important differential diagnosis
n this tumor, because cystic changes in desmoid tumors have
een reported in a few cases, particularly those arising from the
ancreas.15–17 Desmoid-type ﬁbromatosis is a locally aggressive
nﬁltrative intra-muscular ﬁbrous tumor, in spite of benign histo-
ogic feature. Frequent recurrences can be clinically observed even
fter wide resection. A “wait-and-see” strategy is, at the present
ime, preferred in case of asymptomatic or non-progressive disease.
edical treatment such as cyclooxygenase-2 selective inhibitor is
nother choice for the patients with desmoid-type ﬁbromatosis.18
s we can see in this case, the importance of molecular patho-
ogical diagnosis is clinically increasing, especially in the ﬁeld of
oft tissue sarcomas, because the deﬁnite diagnosis made by the
olecular pathology such as RT-PCR and speciﬁc genetic testing
ometimes leads to the application of the tumor speciﬁc therapy,19
lthough so far there is no speciﬁc molecular therapy targeted for
he FUS-CREB3L2 or FUS-CREB3L1 gene fusion. In this case, deep
ocation of the tumor and the characteristic histological features of
land spindle cells arranged in a whorled pattern with alternating
brous and myxoid stroma on the surgically resected tumor con-
rmed the diagnosis of LGFMS. To the best of our knowledge, the
urrent patient at 77 years of age appears to the second elderly
atient diagnosed with LGFMS. Recently, LGFMS was  shown to be
ssociated with gene fusions involving CREB3-family genes, which
ncode members of the basic leucine zipper family of transcription
actors.20 The majority of LGFMS cases (95%) have a fusion of the
US-CREB3L2, and a minority of cases (5%) have a FUS-CREB3L1 gene
usion. In addition, a small number of cases have EWSR-CREB3L1
ene fusions.7 The present case harbored an exon6/exon5 type FUS-
REB3L2 fusion gene. Although a 4-bp insertion of unknown origin
as observed at the junctional region, genome sequencing of theusion gene revealed that this 4-bp insertion was likely derived
rom intron 6 at the junctional region.
Approximately 30% of LGFMS have focal areas of intermediate-
o high-grade sarcoma, which is inconsistent with a deﬁnition ofor macroscopically showed a necrotic area with cystic change in the center of the
myxoid and ﬁbrous areas (B). A whorled growth pattern with bland spindle-shaped
f the tumor (D).
low-grade sarcoma,3 and tumor necrosis is described to be rare
or absent in LGFMS.3,5,6 In this case, hypercellularity, increased
mitotic activity, and nuclear enlargement were seldom observed
throughout the lesion; however, central hemorrhagic necrosis was
observed. This is probably due to the long-time duration of the
tumor and the physical compression of the tumor.
In summary, we report a rare case of LGFMS with central hemor-
rhagic necrosis in a 77-year-old man. To the best of our knowledge,
this is the second elderly patient to be diagnosed with LGFMS.
Although the patient was disease-free at 4 months after surgery,
further long-term follow up is needed.
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